Congresswomen press FDA on why a proposal to ban hair-straightening chemicals is delayed

Two U.S. House members who first pushed the Food and Drug Administration in 2023 to investigate the health risks of hair straighteners used primarily by Black women are now asking the agency why it has twice delayed its target date to propose a ban on products containing formaldehyde, which studies link to increased rates of cancer.

Democratic Reps. Ayanna Pressley of Massachusetts and Shontel Brown of Ohio pressed the FDA in a letter to finalize the proposed rule for banning certain salon-grade and at-home hair straighteners. Rep. Nydia Velazquez of New York joined Pressley and Brown in spearheading the letter, which was dated Tuesday.

The FDA gave notice of a possible rule in 2023 with an initial target date to release the proposal in April. That was then moved to July before jumping to September.

The letter from Pressley, Brown and Velazquez — all of whom are up for re-election this year — asks FDA Commissioner Robert Califf to provide specific reasons for the delay.

Pressley told The Associated Press that Black women look to straightening treatments in part because of hair discrimination.

<bsp-list-loadmore data-module="" class=«PageListStandardB» data-gtm-region=«RELATED COVERAGE» data-gtm-topic=«No Value» data-show-loadmore=«true» data-gtm-modulestyle=«List B»> <bsp-custom-headline custom-headline=«div»> RELATED COVERAGE </bsp-custom-headline> <bsp-custom-headline custom-headline=«div»> FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study </bsp-custom-headline> <bsp-custom-headline custom-headline=«div»> FDA approves first nasal spray to treat dangerous allergic reactions </bsp-custom-headline> <bsp-custom-headline custom-headline=«div»> FDA warns about more ground cinnamon tainted